ClinicalTrials.gg
RecruitingNCT06472115Updated Feb 25, 2026

Parent-Mediated Intervention Targeting Insistence on Sameness for Autistic Children

An interventional study of Supportive Parenting for Anxious Childhood Emotions (SPACE) for insistence on sameness (IS) in Autism Spectrum Disorder and Autism, sponsored by Stanford University. Recruiting at 1 site in United States. Open to participants aged 6 Years to 11 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-02-25.

Primary conditionAutistic DisorderRegistry: Autism Spectrum DisorderReclassifiedWhy we changed it
Registry
Autism Spectrum Disorder — the first condition term the registry derived for this study.
ClinicalTrials.gg
Autistic Disorder
Why
  1. The study's listed conditions name Autistic Disorder, a narrower term within Autism Spectrum Disorder.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Stanford University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Jan 2025; still recruiting 1 year 10 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Not applicable
Ages
6 Years to 11 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 33 studies in Autistic Disorder by Stanford University — 16 open to participants now, 16 under way, none of them phase 3. Autistic Disorder · Stanford University.

Planned enrollment
24th of 33
30 · median 48
Started
2025
with 2 others
No phase
21 of 33
11 open now
Primary completion
2027-10
later than 4 of 15 live
Registered
29th of 33
by date

Among the 33 studies in Autistic Disorder by Stanford University, this one is the 24th largest by planned enrollment, is one of 3 that started in 2025, is one of 21 with no phase, reaches primary completion later than 4 of the 15 other live ones, and was the 29th registered.

Autistic Disorder

1,035 studies on the registry are indexed under Autistic Disorder; 270 are open to participants now.

Browse Autistic Disorder studies →

Open to participants now

16 of the 33 studies in Autistic Disorder by Stanford University are open now, in 1 country. Recruiting first, the newest first:

10 more — sign in →

By country, each count listing its studies:

All 16 open studies →

Where they have run

Who these studies take

Of the 184 Autistic Disorder studies recruiting now, 33 (18%) set no upper age limit and 144 (78%) stop at 75 or younger; 150 take children under 18; 56 take healthy volunteers.

This study: 6 Years to 11 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 33 studies in Autistic Disorder by Stanford University, or all of them as a file.
02

Study summary

This study will examine the potential effectiveness of a virtually delivered parent-mediated intervention for insistence on sameness behaviors in autism and investigate 1) whether caregivers can learn to deliver the adapted Supportive Parenting for Anxious Childhood emotions (SPACE) intervention for IS via telehealth and 2) whether children will show greater improvement in IS behaviors.

03

Conditions studied

  • Autism Spectrum Disorder
  • Autism

Browse trials for

Keywords

  • Supportive Parenting for Anxious Childhood emotions (SPACE)
  • Restricted Behavior
04

In context

Autistic Disorder Reclassified

1,035 studies on the registry are indexed under Autistic Disorder; 270 are open to participants now.

This study's planned enrollment of 30 is below the median of 50 across 814 interventional studies indexed under Autistic Disorder.

Browse Autistic Disorder studies →

Lead sponsor

Stanford University is the lead sponsor of 2,171 studies on the registry; 425 are open to participants now.

Of its 268 completed or terminated interventional studies of FDA-regulated products, 207 (77%) have results posted.

Compared within Autistic Disorder, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Autism Spectrum Disorder. The counts are of registry records indexed under each term, refreshed daily. How we classify →

05

Who can participate

Ages eligible
6 Years to 11 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 6:0 to 10:11 years at the time of consent
  • diagnosed with ASD (based on history, review of available medical records including diagnostic testing completed by psychologist)
  • IQ > or = 75 (based on history, review of available medical records)
  • report three or more family accommodations for insistence on sameness based on screening measures
  • English-speaking parent and youth able to consistently participate in study procedures

Exclusion criteria

Exclusion Criteria:

  • children with significant hearing, language or motor impairment
  • unstable behavioral and pharmacological treatments (e.g., anxiety medication) to treat anxiety or IS behaviors prior to two months to the start of the study and no anticipated changes in treatments during the course of the trial
  • caregivers who have participated in formal SPACE training
  • concurrent psychosocial treatment for anxiety or Insistence on Sameness
  • children who have a history of prominent school refusal, self-harm, or suicidal ideation
06

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Active treatment

    Eligible participants that enroll will received 16 week parent based intervention for insistence on sameness

    Behavioral: Supportive Parenting for Anxious Childhood Emotions (SPACE) for insistence on sameness (IS)

Interventions

  • BehavioralSupportive Parenting for Anxious Childhood Emotions (SPACE) for insistence on sameness (IS)

    This study will examine the potential effectiveness of a virtually delivered parent-mediated intervention for insistence on sameness behaviors in autism. This includes a 16 week protocol where caregivers meet weekly for one hour with a study therapist.

07

What researchers measure

Primary outcomes

  1. Change from baseline in parent rated Dimensional Assessment of Restricted Behavior (DARB) Scores during treatment.

    DARB scores measure restricted and repetitive behaviors with higher scores indicating greater intensity.

    Time frame: Screening, Baseline, Weeks 4, 8, 12, 16 and 2 month follow up

  2. Change from baseline in clinician rated clinical global impressions scale scores during treatment.

    Score Range: 1 = normal, not at all ill; 7 = among the most extremely ill patients; 1 = very much informed since the initiation of treatment; 7 = very much worse since the initiation of treatment.

    Time frame: Weeks 8, 16 and 2 month follow up

Secondary outcomes

  1. Change from Baseline in Parent-Rated Anxiety as captured by the Anxiety Scale for Children with Autism Spectrum Disorder (ASC-ASD).

    ASC-ASD captures anxiety with higher scores indicating greater anxiety severity across the subdomains of separation anxiety, uncertainty, performance anxiety, and anxious arousal. \[Score Range: 0-72\]

    Time frame: Baseline, Week 16 and 2 month Follow up

  2. Change in Emotion Regulation Checklist scores during treatment

    The Emotion Regulation Checklist (ERC) is a 24-item measure of children's self-regulation completed by a caregiver. Items are rated along a continuum (1=rarely, 4=almost always). Higher scores on the Lability/Negativity sub scale indicate more difficulty managing and coping with emotions, while higher scores on the Emotion Regulation sub scale indicate better ability to self-regulate.

    Time frame: Baseline, 16 week

  3. Change in Daily Living Skills Scale Scores during treatment

    Higher scores indicate better ability on the DLSS. \[Score Range: 0-53\]

    Time frame: Baseline, 16 week, 2 month Follow up

  4. Change in Open Source - Challenging Behavior scores during treatment

    Higher levels indicate greater levels of challenging behavior and lower levels indicate improvement.

    Time frame: Baseline, 16 weeks, 2 month Follow Up

08

Study locations

1 of 1 sites recruiting
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2025 (actual). Primary completion is estimated for Oct 2027, 32 months after the start.

Of 355 non-industry interventional studies with no phase under Autistic Disorder, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 50. This study's planned 32 months is above that.

Counting every sponsor, half of 367 studies reached it within 26 months; a quarter within 13 and three quarters within 50.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 17, 2024
First posted
Jun 24, 2024
StartActual
Jan 5, 2025
Primary completionEst.
Oct 1, 2027
CompletionEst.
Oct 1, 2027
Last update
Feb 25, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 25, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06472115
Responsible party
Jennifer Phillips (Professor of Psychiatry and Behavioral Sciences, Stanford University) — Principal investigator
First posted
Jun 24, 2024
Start date
Jan 5, 2025
Primary completion
Oct 1, 2027 (estimated)
Completion
Oct 1, 2027 (estimated)
Last update
Feb 25, 2026

Study contacts

Kari Berquist, PhD
Contact
spacestudy@stanford.edu
(650) 724-6026
Jennifer Phillips, PhD
principal investigator · Stanford University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion